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Abstract: Okadaic acid (OA) has been an invaluable pharmacological tool in the study of 
cellular signaling. The great affinity of this polyether for its targets together with its high 
specificity to inhibit certain protein phosphatases enables the differential study of these 
proteins. Crystallographic structures of protein phosphatases in complex with OA show a 
1:1 protein to toxin ratio. Nevertheless, it has been found that OA is able to self-associate 
under certain conditions although very little is known about the importance of this 
phenomenon. Here we review the available knowledge on the latter topic and we report on 
the existence of an unusual self-associated tetrameric form. The structure of these oligomers 
is proposed based on spectroscopic data and molecular modeling calculations. 
Keywords: okadaic acid; protein phosphatase; nuclear magnetic resonance; scanning 
tunneling microscopy 
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1. Introduction 
Okadaic acid (OA) is well known for being the main culprit of the diarrhetic shellfish poisoning, 
also known as DSP syndrome, a phenomena with important consequences for the human health and 
the fishery industry; but it has also been an invaluable pharmacological tool in the study of cellular 
signaling [1,2]. OA was originally isolated from the black sponge Halichondria okadai by a Japanese 
pharmaceutical company, but it was later discovered that marine dinoflagellates of the Dinophysis and 
Prorocentrum genera were its genuine originator [3]. The structures of the o-bromobenzyl ester of OA 
as well as that of its episulfide, acanthifolicin, were originally determined by X-ray crystallography [4,5]. 
Subsequently, the conformation of OA in solution was also elucidated by NMR spectroscopy in two 
different studies that found a major similarity with that obtained for the solid-state structure [6,7]. 
Afterwards, in the late 1980s, a study of the cellular regulatory mechanisms underpinning muscle 
contraction produced by OA showed that it was mediated by inhibition of the phosphatase that 
dephosphorylates myosin light chains [8,9]. As part of this research, a seminal work by Bialojan and 
Takai, they compared the effects of OA helped to distinguish between different protein phosphatases. 
This result was considered a milestone in cell signaling research [10]. Consequently, OA is probably 
the best known phosphatase inhibitor and has been profusely used to study the cellular role of these 
proteins [11]. Due to its high but different affinity for protein phosphatases type 1 (10–100 nM) and 
type 2A (0.1–1 nM), OA has been used in several structure-activity studies looking for selective 
phosphatase inhibition [12,13]. More recently, the structures of the two main targets of OA, the protein 
phosphatases type 1 (PP1) and 2A (PP2A) were reported in complex with this toxin [14,15]. The 
availability of these structures and the discovery of new inhibitors have allowed a better understanding 
of the molecular basis underpinning the observed differences in protein selectivity [16–18], and could 
be the opening for the design of new drugs targeting cell signaling by protein phosphatase  
inhibition [19]. 
2. Dimerization of Okadaic Acid Overview 
2.1. Complexation of Okadaic Acid 
Norte et al. first reported in 1991 that the toxin was usually isolated from cultures of P. belizeanum 
as a complex with an unknown ion [6]. At first glance, the main characteristic of the complexed form 
of okadaic acid (OAC) NMR spectra was its low resolution. Nevertheless, sample treatment with an 
ion chelator such as EDTA, modified the spectrum that became well resolved. In addition, signals from 
H-7, H-12, H-14, H-15, H-23 and Me-41 clearly changed their chemical shifts upon addition of EDTA 
(Figure 1). Following this opening observation, a series of experiments were carried out in order to 
identify the ion included in this complex [20]. The experiments consisted of the treatment of OA 
samples with different metal ions such as Li
+
, Na
+
, K
+
, Ca
2+
 and Mg
2+
. Those ions were selected based 
on the hypothesis that the genuine one should have a physiologically relevant role and must have an 
atomic volume that could fit into a “cavity” formed by OA units. In fact, treatment of OA with K+ salts 
resulted in 
1
H-NMR spectra that resembled those of the naturally isolated samples, giving an important 
clue about the ion identity. 
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Figure 1. 
1
H-NMR spectra of okadaic acid (upper left corner), its complex (bottom left 
corner) and section of the ROESY of the complex in CDCl3 (right). 
 
2.2. Physiological Importance of the Potassium Ion 
Further confirmation of the ion nature was obtained from pharmacological experiments [20]. 
Briefly, taking into account that OA induces smooth muscle contractions, rat uterine strips were 
incubated either with OA or OAC in Ca
2+
, Na
+
 or K
+
 free PSS media. The outcome was that while the 
physiological effect of OAC was maintained in a K
+
 free solution, the activity of OA was severely 
reduced, confirming the previous observations and indicating that the potassium ion was involved in 
the mechanism of action of this toxin. 
2.3. Structure of the Okadaic Acid—Potassium Complex 
The aforementioned pharmacological results encouraged the authors to start a structural study of 
OAC in solution in order to explain the physiological importance of the complex [21]. Surprisingly, 
the NOESY spectrum of a 1 mg/mL sample of OAC recorded in CDCl3 did not show cross-correlated 
signals contrary to what had been observed for OA. This observation suggested that both species have 
different correlation times, and that the molecular volume of OAC was larger than that of OA. This 
conclusion was confirmed by measurements of translational diffusion coefficients in CDCl3 obtained 
from NMR Diffusion-Ordered SpectroscopY (DOSY). Conversion of these measurements into 
apparent molecular weights (Mapp) using the Stokes-Einstein equation corroborated that two units of 
OA formed OAC in CDCl3 solution. In contrast, DOSY experiments performed in water showed little 
differences between the two species (OA and OAC), suggesting that the monomer-dimer equilibrium 
in this solvent is shifted to the monomeric species. Finally, our findings were reinforced by mass 
spectrometry experiments, where it was observed that ESI-MS of OAC samples isolated from cultures 
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exhibited characteristic [OA2 + K + H2O]
+
 and [OA2 + K]
+
 peaks, confirming that OAC was a dimer of 
OA and that the potassium ion was part of it. Next, measuring 
1
H-
1
H coupling constants and using 
distance constrains derived from the ROESY experiment (Figure 1), a molecular model of OAC was 
built based on Monte Carlo conformational searches. At this point, it is worth considering that one 
additional and very important restriction imposed to the produced model was its necessary symmetry 
as it was deduced from the absence of NMR signal duplication. The outcome was a model where the 
potassium ion-binding site was formed by three oxygen atoms attached to C-7 and C-8 of each OA 
monomer (Figure 2). The proposed structure therefore has a polar coordination site buried by a 
hydrophobic surface [21]. Thereafter, we considered the possibility that this structure could be a means 
of improving OA membrane permeability in accordance with the fact that the dimer was mainly found 
in CDCl3—a solvent that somehow mimics the lipid bilayer environment—and keeping in mind the 
bioactivity results obtained from experiments performed in tissues. 
Figure 2. Structure proposed for the okadaic acid—potassium complex [21]. Each okadaic 
acid monomer is shown in a different color while K
+
 is shown as a purple sphere. 
 
2.4. Dimerization as a Pathway to the Cell 
In order to confirm the previous hypothesis, additional experiments were undertaken. However, we 
faced the problem of resolving the aggregation status of a symmetric molecule when it is interacting 
with membranes despite its difficult. As an alternative, we designed an experiment that used Scanning 
Tunneling Microscopy (STM) as a detection technique. Using this technique it is possible to measure 
particle sizes, therefore it was feasible to differentiate between particles formed by one or two units of 
OA, therefore the formation the dimers mediated by K
+
 ions was verified (Figure 3). Subsequently, a 
simplified model to study the transport of the toxin through a lipid bilayer was built separating two 
KCl aqueous solutions by a lipid bilayer [22]. One solution had the K
+
 concentration that can be found 
in the intracellular medium (100 mM) while the other contained 0.5 mM of OA and 5 mM of the same 
electrolyte (equivalent to the extracellular concentration). The detector, a gold plate, was placed into 
the 100 mM KCl solution but only when a −90 mV potential was applied (equivalent to the membrane 
potential), OA molecules circulated through the lipid bilayer and were subsequently adsorbed onto the 
gold plate. Analysis of the plate by STM indicated that the particle size distribution was shifted to 
higher values, matching those calculated for OA dimers (Figure 3). 
Mar. Drugs 2013, 11 1870 
 
 
Figure 3. (A) STM image of an okadaic acid (OA) sample and (B) its corresponding 
histogram of size distribution. (C) and (D) are the corresponding figures of okadaic acid in 
a KCl solution. On the right side of the figure, a schematic representation of the experimental 
setup used to monitor the flux of OA through a lipid bilayer. (E) corresponds to a section 
of the gold plate used to monitor the experiment and (F) is the cross section of one spot. 
 
As a consequence, we proposed that in order to move through biological membranes OA should 
dimerize. Once the dimer reaches the cytoplasm, the equilibrium is shifted back to the monomer, in 
accordance with the DOSY results carried out in water. In this way, the toxin would be able to interact 
as a monomer with their main cellular targets, the serine-threonine protein-phosphatases type 1 and 2A 
(Figure 4). 
Figure 4. Schematic representation of the hypothetical mechanism followed by okadaic 
acid to cross cellular membranes. Okadaic acid monomers (in red) would bind a potassium 
ion (purple sphere) from the extracellular media in order to form a dimer with a 
hydrophobic surface (in blue), that would cross lipid bilayers allowing the toxin to bind the 
catalytic subunit of protein phosphatases (PP2A in green [15]). 
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3. Results and Discussion 
3.1. Higher Oligomerization States of Okadaic Acid 
In our experience, during the isolation of OA from cultures of the dinoflagellate Prorocentrum 
lima, it is common to notice slightly different chromatographic behaviors between different batches. 
Nevertheless, their NMR spectra are equivalent to those reported in either the monomeric or the 
dimeric forms of okadaic acid. In this way, using an OA sample eluted at a different chromatographic 
retention time, which 
1
H NMR spectra resembled that previously reported for the dimeric form of 
okadaic acid, a nanospray ESI-MS spectrum was acquired. The unexpected outcome was the presence 
of an additional clear peak at m/z 3336.25. This result implies the co-existence of monomeric and 
dimeric species, also observed in the spectra at m/z 1697.4 [(OA)2 + H2O + MeOH + K]
+
 and 1649.4 
[(OA)2 + H2O + Na]
+
, with higher molecular weight species that according to its molecular weight 
should be formed by four units of OA. As this observation cannot be considered conclusive, we looked 
for further experimental evidences that support the existence of tetramers in solution. NMR 
measurements were not adequate, because, as described previously, OAC samples in CDCl3 solution 
behave mainly as dimers, according to its diffusion coefficient. However, such measurements do not 
discard the existence of minor populations of monomers and/or tetramers. Considering that we have 
successfully used scanning tunneling microscopy (STM) to confirm the existence of dimeric forms of 
OA [22], we decided to follow a similar approach to confirm the existence of its tetrameric forms. In 
order to do this, a gold plate was dipped into a methanol solution of OA (10 mg/mL) and as expected, 
a gold surface mainly covered by 40–45 Å particles that correspond to OA dimers (Figure 5). It was 
also possible to find a small number of particles of 20–25 Å, consistent with the presence of OA 
monomers, and more interestingly, OA aggregates of 50–60 Å that can be rationalized by the existence 
of OA tetramers. Therefore, this experiment confirmed that monomer/dimer/tetramer species coexist  
in solution. 
Figure 5. Representative STM images obtained after dipping a gold plate into an okadaic 
acid methanol solution. The left panel is a 20 nm × 20 nm section from an overhead 
viewpoint. The right panel is a cross-section corresponding to an okadaic acid tetramer 
obtained from the same area. 
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3.2. Structure of Okadaic Acid Tetramers 
Once the existence of OA tetramers was confirmed, a series of NMR spectra were acquired in order 
to obtain structural information at an atomic level. However, no additional information was found as 
the observed 
1
H and 
13
C-NMR chemical shifts of the studied samples matched very well with those of 
the dimeric species. In addition, the ROESY experiment showed the same dipolar correlations that can 
be observed in the dimeric form of OAC (H-4/H-41 and H-12/H-26) that allowed us to propose a 
structure for the dimeric form (Figures 1 and 2). Moreover, the absence of new signals is indicative of 
the existence of a symmetric arrangement of the molecules involved. However, the structural 
determination of symmetric polymeric species by NMR techniques is a very difficult task. The main 
reason is the impossibility to differentiate between equivalent atoms precluding the use of angular or 
distance constrains obtained either from coupling constant or NOE measurements. Unfortunately, 
despite different conditions being assessed, we were not able to obtain crystals that could be use by  
X-ray crystallography techniques. Nevertheless, taking into account that the NMR data perfectly 
matches that already published for the dimer, we considered that the tetrameric form of OA should be 
formed by the combination of two dimers in a symmetric arrangement; in other words, it should be a 
dimer of dimers. Therefore, using these structural data, we have used a molecular modeling approach 
to propose a three-dimensional structure of the okadaic acid tetramer. 
Taking into account the scarce structural data available and using the ClusPro software, we explored 
the conformational space in order to predict the structure of the complex [23]. 20,000 different 
dockings between two dimers were generated and afterwards only those structures with symmetric 
elements were selected, resulting in 76 tetrameric structures. Afterwards, these structures were 
clustered using the X-Cluster software as implemented in MacroModel 8.5 and as a result, seven 
different structural families were obtained (Figures 6 and 7) [24]. 
After a careful analysis of these seven representative structures, we concluded that only the 
structure of one of them, family in Figure 7, could satisfy all previously described structural features of 
our sample. Certainly, only structure G keeps the C-30–C-38 moiety of each OA unit far away from 
each other as they are in the dimer, a characteristic that would result in very similar chemical shifts as 
compared to those observed for the dimer. On the other hand, in all other structures (A–F) new 
contacts between at least two of these C-30–C-38 fragments would be observed, resulting in important 
changes in their corresponding chemical shifts. In addition, structure G also maintains the hydrophilic 
cavity where three molecules of solvent can be fitted, according to the molecular weight found in the 
MS experiment m/z 3336.25 [(OA)4 + (MeOH)3 + Na]
+
. This model is consistent with the chemical 
structure: Four units of OA that are symmetrically organized and an internal cavity where three 
molecules of solvent can be accommodated. Finally, it should be noted that the dimensions of the 
selected structure corresponds quite well with the dimensions determined for the tetramer according to 
the cross section measured in the STM image (Figure 5). 
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Figure 6. Representation of the different structural families of okadaic acid tetramers as 
obtained from the X-Cluster software. In this figure, OA units forming each dimer are in 
different shades of the same color (dark and light blue, and dark and light brown). 
  
Figure 7. Sterereoviews of the proposed structure of the tetrameric form of okadaic acid. 
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4. Experimental Section 
4.1. Spectroscopic and Spectrometric Techniques 
NMR spectra were performed on a Bruker AVANCE 400 MHz instrument. 
1
H and 
13
C NMR 
chemical shifts are referenced to the CD3OD solvent peak (δH 7.26 ppm and δC 77.0 ppm) at 300 K. 
The compound was dissolved in 250 L of CDCl3 in a Shigemi tube. Phase-sensitive ROESY spectra 
were measured using a mixing time of 400 ms as the intensity of the NOESY cross-peaks were close to 
zero at room temperature. Data were processed using Topspin or MestReC software. Mass spectra 
were recorded in a Thermo Finnigan LQC spectrometer, quipped with a NanoSpray source, and the 
sample was applied dissolved in MeOH at 50 nL/min flow. STM images (constant current mode) were 
taken with a Nanoscope IIE (Digital Instrument, Santa Barbara, CA) using both, commercial and 
electrochemically etched Pt-Ir tips. All samples were thoroughly rinsed with water, methanol and dried 
and under N2 flow for several hours before imaging. All images were taken in air at room temperature. 
Typical tunneling current and applied bias voltages to obtain good quality images were 0.2–0.4 nA and 
0.3–0.6 V respectively at scan rates ranging 0.5–2 Hz. The STM images shown here constitute 
representative results. Au plates (Arrandee™) were used as substrate. These plates after a flame 
annealing consist of micrometer-sized Au (111) preferred oriented crystals with atomically smooth 
triangular terraces separated by monatomic steps in height. The height of these steps (2.4–2.6 Å) was 
used to calibrate the piezotube of the STM in the z direction. Some of the images were analyzed by 
using WSxM software [25]. TLC was performed on AL Si gel Merck 60 F254, and TLC plates were 
visualized by spraying with phosphomolybdic acid reagent and heating. 
4.2. Prorocentrum Belizeanum Cultures 
A 3 mL sample of a clonal culture (7000 cells/mL) of the dinoflagellate Prorocentrum belizeanum 
(PBMA01), originally isolated from a coral reef of La Réunion Island (Indian Ocean, France), was 
obtained from the IEO culture collection (Vigo, Spain), by courtesy of Mr. Santiago Fraga.  
Large–scale cultures of P. belizeanum were performed in 80 L tanks containing 40 L of seawater 
enriched with Guillard K medium at 23 ± 1 °C, with irradiance of 60 µE/s/m
2
 and under an 18:6 
light/darkness photocycle. Cultures were incubated statically for 50 days up to a final volume of 750 L. 
4.3. Extraction, Isolation and Purification 
Due to the benthonic nature of the dinoflagellate P. belizeanum, most of the supernatant was easily 
separated by decantation and cells were harvested by centrifugation (3700× g for 10 min at 4 °C). The 
cells were sonicated and successively extracted with acetone (5 × 800 mL) and then with methanol  
(5 × 800 mL) to obtain two separated extracts. The methanol extract (14.95 g) was chromatographed 
on a Sephadex LH-20 column (60 × 350 mm) eluted with methanol and then fractionated using a 
Lobar LiChroprep RP8 column (25 × 310 mm) eluted with CH3OH/H2O (7:3). The selected fraction 
(0.05 g) was subjected to gel filtration on a Sephadex LH-20 column (10 × 150 mm) eluted with 
CH3OH/CHCl3 (1:2). Final purification of okadaic acid (50 mg) was achieved by semi preparative 
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reversed-phase HPLC (XTerra Prep C18 10 µm, 19 × 150 mm, 1.0 mL/min flux) using an isocratic 
elution of CH3OH/H2O (17:3). 
4.4. Preparation of STM Gold Plate 
The gold plated was dipped in a 10 mg/mL OA (12.4 mM) methanol solution for 5 min. This was 
washed with methanol, dried and analyzed by STM microscopy at 1 nm/div. 
5. Conclusions 
In this article, we have reviewed the existing knowledge about the dimerization of okadaic acid, the 
implication of metal ions in this process and their possible physiological implications. The elucidation 
of the okadaic acid dimer structure in solution was also reviewed. The proposed structure shows a 
hydrophobic surface that would increase membrane permeability of the toxin, providing structural 
clues about the physiological importance of dimerization as well as about the role of potassium ion 
observed in the in vivo action of OA. The exact role of the dimeric species of OA is uncertain but our 
results indicate that it is vital for the membrane transport of the toxin. Although self-association is not 
a common phenomenon in marine toxins, it has been observed in brevetoxin-B where transmembrane 
self-assembly was proposed to explain cation transport via a “channel-like” mechanism and in 
palytoxin where a dimeric structure has been recently determined by means of SAXS and NMR 
spectroscopy, although no physiological consequences have been proposed for the latter [26–28].  
In addition, although the results are not conclusive, our mass spectrometry, NMR spectroscopy and 
STM imaging experiments suggest, that the marine polyether toxin okadaic acid self-associates to form 
a tetramer when it is in high concentration coexisting with monomers and dimers of the toxin.  
Finally, utilizing molecular modeling techniques, we propose a structure for the tetrameric form of 
okadaic acid. 
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